Abstract: The present invention provides for novel amorphous solid dispersions of form of cabozantinib malate, and a pharmaceutically acceptable excipient and process for the preparation of cabozantinib malate. The invention also provides a novel crystalline polymorph of cabozantinib.
| # | Name | Date |
|---|---|---|
| 1 | 202347070534-STATEMENT OF UNDERTAKING (FORM 3) [17-10-2023(online)].pdf | 2023-10-17 |
| 2 | 202347070534-PRIORITY DOCUMENTS [17-10-2023(online)].pdf | 2023-10-17 |
| 3 | 202347070534-FORM 1 [17-10-2023(online)].pdf | 2023-10-17 |
| 4 | 202347070534-DRAWINGS [17-10-2023(online)].pdf | 2023-10-17 |
| 5 | 202347070534-DECLARATION OF INVENTORSHIP (FORM 5) [17-10-2023(online)].pdf | 2023-10-17 |
| 6 | 202347070534-COMPLETE SPECIFICATION [17-10-2023(online)].pdf | 2023-10-17 |
| 7 | 202347070534-Proof of Right [04-12-2023(online)].pdf | 2023-12-04 |
| 8 | 202347070534-FORM-26 [18-12-2023(online)].pdf | 2023-12-18 |
| 9 | 202347070534-FORM 18 [30-01-2025(online)].pdf | 2025-01-30 |